Spots Global Cancer Trial Database for iobenguane i 131
Every month we try and update this database with for iobenguane i 131 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma | NCT00410631 | Neuroblastoma | filgrastim carboplatin cisplatin cyclophosphamid... dacarbazine doxorubicin hyd... etoposide phosp... ifosfamide isotretinoin melphalan topotecan hydro... vincristine sul... vindesine autologous hema... conventional su... peripheral bloo... iobenguane I 13... radiation thera... | - 21 Years | National Cancer Institute (NCI) | |
| 131 I-MIBG in Treating Patients With Refractory or Relapsed Neuroblastoma | NCT00293319 | Neuroblastoma | filgrastim iobenguane I 13... | 1 Year - | University of California, San Francisco | |
| Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma | NCT00107289 | Neuroblastoma Pheochromocytom... | iobenguane I 13... | 1 Year - | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma | NCT00526318 | Neuroblastoma | filgrastim carboplatin cisplatin cyclophosphamid... dacarbazine doxorubicin hyd... etoposide phosp... ifosfamide isotretinoin melphalan topotecan hydro... vincristine sul... vindesine autologous hema... iobenguane I 13... radiation thera... | - 21 Years | National Cancer Institute (NCI) | |
| N2004-06: Irinotecan and Vincristine With 131I-MIBG Therapy for Resistant/Relapsed High-Risk Neuroblastoma | NCT00509353 | Neuroblastoma | irinotecan hydr... vincristine sul... iobenguane I 13... | 1 Year - 30 Years | Children's Hospital Los Angeles | |
| Expanded Access Program of Ultratrace Iobenguane I131 for Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma | NCT02961491 | Pheochromocytom... Paraganglioma | Ultratrace Iobe... | 12 Years - | Molecular Insight Pharmaceuticals, Inc. | |
| Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma | NCT00107289 | Neuroblastoma Pheochromocytom... | iobenguane I 13... | 1 Year - | Memorial Sloan Kettering Cancer Center | |
| N99-01: Combination Chemotherapy, Radiation Therapy, and Stem Cell Transplantation in Treating Patients With Neuroblastoma | NCT00005978 | Neuroblastoma | filgrastim carboplatin etoposide melphalan autologous bone... peripheral bloo... iobenguane I 13... radiation thera... | 1 Year - 21 Years | New Approaches to Neuroblastoma Therapy Consortium | |
| Iodobenzylguanidine Meta-I131 and Topotecan in Young Patients With Refractory or Relapsed Metastatic Neuroblastoma | NCT00960739 | Neuroblastoma | Topotecan hydro... Autologous hema... iobenguane I 13... total-body irra... | 1 Year - 20 Years | Centre Oscar Lambret | |
| Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma | NCT00526318 | Neuroblastoma | filgrastim carboplatin cisplatin cyclophosphamid... dacarbazine doxorubicin hyd... etoposide phosp... ifosfamide isotretinoin melphalan topotecan hydro... vincristine sul... vindesine autologous hema... iobenguane I 13... radiation thera... | - 21 Years | National Cancer Institute (NCI) | |
| N2000-01: Double Infusion of Iodine I 131 Metaiodobenzylguanidine Followed by Autologous Stem Cell Transplantation | NCT00083135 | Neuroblastoma | filgrastim autologous bone... peripheral bloo... iobenguane I 13... | 1 Year - 30 Years | Children's Hospital Los Angeles | |
| Iodobenzylguanidine Meta-I131 and Topotecan in Young Patients With Refractory or Relapsed Metastatic Neuroblastoma | NCT00960739 | Neuroblastoma | Topotecan hydro... Autologous hema... iobenguane I 13... total-body irra... | 1 Year - 20 Years | Centre Oscar Lambret |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
